|
Delayed
OTC Markets
07:40:59 22/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.0280 USD | -12.50% |
|
-15.92% | +7.69% |
| 19/05 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 17/11 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 84.82L | - | - | - | - | - |
| 1,13300Cr | |||||
| 62TCr | |||||
| 50TCr | |||||
| 38TCr | |||||
| 37TCr |
Select your edition
All financial news and data tailored to specific country editions
